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Rat liver fructose 1,6-bisphosphatase can be protected against partial inactivation by N-ethylmaleimide by 
low concentrations of fructose 2,6-bisphosphate or high concentrations of fructose 1,6-bisphosphate. The 
partially inactivated enzyme has a much reduced sensitivity to high substrate inhibition and has lost the 
sigmoid component of the inhibition by fructose 2,~bisphosphate; this compound is a simple linear 
competitive inhibitor of the modified enzyme. The results suggest hat fructose 2,dbisphosphate can bind 
to the enzyme at two distinct sites, the catalytic site and an allosteric site. High levels of fructose 
1,6-bisphosphate probably inhibit by binding to the allosteric site. 
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1. INTRODUCTION 
Fructose 2,6-bisphosphate (F2,6Pz) is thought to 
play a key role in the regulation of carbohydrate 
metabolism in liver [l]. Its level in liver varies in 
response to hormones and to changes in dietary 
status. It is an activator of phosphofructokinase 
and an inhibitor of fructose 1,6-bisphosphatase 
(Fl,(iPzase) and its level could therefore control 
glycolysis and gluconeogenesis at the level of the 
fructose 6-phosphate-fructose 1 ,dbisphosphate 
(Fl,6P2) cycle [l]. 
There has been considerable controversy regar- 
ding the mechanism of the inhibition of liver 
F1,6P~ases by F2,6Pz. In [2] it was reported that 
F2,6P2 was a simple competitive inhibitor of rat 
liver F1,6Pzase with respect to F1,6P2 and they 
concluded that F2,6P2 interacted with the enzyme 
at the catalytic site. Similar conclusions have been 
drawn from kinetic and chemical modification 
data for the F1,6Pzases from rabbit and pig liver 
[3,4]. However, authors in [5] argued that the in- 
hibition of rat liver Fl,ciPzase by F2,6P2 was more 
complex than this. They showed that in kinetic ex- 
periments FZ,6P2 reduced the affinity of the en- 
zyme for F1,6Pz and also induced co-operativity in 
the response to F1,6Pz. There is also general agree- 
ment that the inhibitions of liver F1,6Ptases by 
AMP and F2,6P2 are synergistic f2-61. Moreover, 
F2,6Pz but not Fl,6Pz can protect the AMP- 
binding properties of rat liver F1,6Pzase against 
modification by acetylimidazole 161. These 3 fin- 
dings are consistent with the idea that F2,6Pz in- 
teracts with an allosteric site on F1,6Pzase distinct 
from both the catalytic site and the AMP site. 
We report here observations that suggest that 
F2,6P2 can interact with two distinct sites on rat 
liver F1,6Pzase and we propose that high substrate 
inhibition of liver Fl,CiPzases results from binding 
of Fl,6Pz to the allosteric site for F2,6P2. 
2. MATERIALS AND METHODS 
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Glucose 6-phosphate dehydrogenase, 
phosphoglucose isomerase, NADP+, F1,6P2 and 
Published by ELFevier Science Publishers B. V. 
00145793/83/$3.00 0 1983 Federation of European Biochemical Societies 105 
Volume 160, number 1,2 FEBSLETTERS August 1983 
triethanolamine hydrochloride were obtained from 
Boehringer (London). N-Ethylmaleimide (NEM) 
was obtained from Aldrich (Gillingham). 
5,S1-Dithio-bis-(2nitrobenzoate) (Nbsz) was ob- 
tained from Sigma (London). F2,6P2 was prepared 
using a minor modification of the method in [7]; 
during the hydrolysis of Fl,6P2 by F1,6Pzase, 
10 mM MgCl2 was used instead of 0.5 mM MnClz. 
All other chemicals were of the highest available 
purity. 
F1,6Pzase was purified to homogeneity from rat 
liver by a method involving fractionation with 
(NH&S04 and chromatography on DEAE- 
cellulose, Procion red-Sepharose and Sephadex 
G200 [8]. The purified enzyme was free from pro- 
teolytic degradation as judged by its subunit 
molecular mass, its sensitivity to AMP and its pH- 
activity profile [8]. For treatment with N- 
ethylmaleimide the enzyme (0.125 mg/ml) was in- 
cubated in 50 mM triethanolamine 
hydrochloride-KOH (pH 7.5) containing 100 mM 
KC1 and the additions indicated in the text at 0°C. 
At zero time NEM was added to a final concentra- 
tion of 25 PM. Samples were removed at various 
times and assayed for Fl,6Pzase using the standard 
assay. 
F1,6Pzase was assayed by coupling the produc- 
tion of fructose 6-phosphate to the reduction of 
NADP+. The standard assay conditions were those 
given in (91. For kinetic experiments (fig.2,3) a 
slightly modified method was used; each cuvette 
contained, in 2 ml, 50 mM triethanolamine 
hydrochloride-KOH (pH 7.2), 100 mM KCl, 
10 pM EDTA, 0.15 mM NADP+, 5 units of 
phosphoglucose isomerase and 3 units of glucose 
6-phosphate dehydrogenase. The concentrations 
of free Mg2+, F1,6Pz and F2,6P2 were as stated in 
the text. The reaction was initiated by the addition 
of F1,6Pzase and the reduction of NADP+ was 
monitored at 25°C using a Hitachi Perkin-Elmer 
MPF 2A spectrofluorimeter. The excitation and 
emission wavelengths were 340 nm and 460 nm, 
respectively, and the instrument was adjusted to 
give a full scale deflection corresponding to 0.5 PM 
NADPH. The association constant for the 
Mg2+-Fl,6P2 complex was taken to be 250 M-’ 
[lo] and that for the Mg’+-F2,6P2 complex was 
found to be 350 M-’ using the method in [ll]. 
Kinetic plots were analysed using a weighted least 
mean squares linear regression method [ 121. 
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3. RESULTS AND DISCUSSION 
Liver F1,6Pzases are inhibited by high levels of 
F1,6Pz (e.g., [10,13]). Treatment of an ox liver 
F1,6Pzase with p-chloromercuribenzoate abolished 
the sensitivity of the enzyme to this high substrate 
inhibition but did not greatly affect its catalytic 
properties or its allosteric response to AMP [lo]. 
Moreover, inhibitory levels of F1,6Pz, but not 
non-inhibitory levels, protected the enzyme against 
thiol group reagents [lo]. These observations ug- 
gest that the inhibition of liver F1,6P2ases by high 
levels of Fl,6P2 may be mediated by low affinity 
binding of F1,6Pz to a site distinct from the 
catalytic site; this site could be an allosteric F2,6P2 
site. 
Titration of the thiol groups of rat liver 
F1,6Pzase with a large excess of Nbs~. revealed the 
presence in the native enzyme of 0.8 rapidly reac- 
ting thiol groups per subunit (not shown). Titra- 
tions carried out in the presence of 8 M urea show- 
ed the presence of 7.0 thiol groups per subunit; this 
is consistent with the cysteine content determined 
by amino acid analysis [8]. The rapid reaction of 
native F1,6Pzase with Nbsz correlated with a 50% 
decrease in the activity of the enzyme. However, 
the activity of the enzyme continued to decline 
slowly even after the reaction with Nbsz had been 
terminated by the addition of excess dithiothreitol 
and so the kinetic properties of Nbsz-modified 
F1,6Pzase were not examined. These results show 
that rat liver F1,6P2ase resembles other F1,6Pzases 
in containing one particularly reactive thiol group 
per subunit. 
The results in fig.1 show that the addition of 
NEM to rat liver F1,6Pzase causes 50-55070 inac- 
tivation of the enzyme in a reaction that is com- 
plete after about 20 min; no further decrease in ac- 
tivity took place over 1 h. F2,6P2 (100 PM) afford- 
ed complete protection against inactivation, and 
Fl,6P2 (5 mM) gave significant, though not com- 
plete, protection (fig.1). The results from a series 
of protection experiments are summarised in table 
1. While 4 FM F2,6P2 gave considerable protection 
and 10pM F2,6P2 gave complete protection, 
200 pM F1,6P2 gave no protection; this concentra- 
tion is about lOO-times the K,,, of the enzyme for 
F1,6P2 [14]. These results show that the target for 
modification by NEM is a high affinity binding site 
for F2,6P2 and a low affinity binding site for 
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Fig.1. The effect of NEM on the activity of rat liver 
Fl,bPsa~. Fl,6Psase was incubated as described in 
section 2. The standard assay for F1,6Pzase was used. 
Symbols represent: no NEM (o), NEM with no other 
additions (0), NEM plus 5 mM F1,6Pz (A), NEM plus 
1OOpM F2,6Pz (A). 
Table 1 
The protection of rat liver Fl$Pzase against inactivation 
by NEM 
Addition Activity 
remaining (olo) 
None 55 
0.2 mM F1,6Pz 58 
5 mM Fl,6P2 94 
0.2 mM AMP 50 
0.2 mM AMP + 0.2 mM Fl,6Pz 54 
5 mM Fructose 6-phosphate 65 
SmMPi 61 
4,uM F2,6Pz 87 
10 pM F2,6P2 98 
100 ,BM F2,6P2 102 
F1,6Pzase was incubated with NEM for 20 min as in 
section 2 with the indicated additions. Activity is 
expressed as a percentage of the value at zero time. No 
activity was lost in the absence of NEM 
0: 
0 50 100 150 200 
[F1,6P21 (MM) 
Fig.2. Dixon plots for the inhibition of control and 
NEM-treated F1,6Pzase by high levels of Fl,6P2. 
Control F1,6Pzase (0), F1,6Psase modified with NEM 
as described in the text (0). The fluo~metric assay was 
used and the free Mg2+ concentration was 2 mM. 
F1,6Pz; it is not the catalytic site. Neither AMP, in 
the presence or absence of Fl,6Pz, nor fructose 
6-phosphate nor Pi afforded any significant pro- 
tection against NEM. 
A sample of rat liver Fl,6Pzase was treated with 
NEM in the absence of any protecting agents. The 
reaction was terminated by the addition of excess 
dithiothreitol after 30 min; the enzyme activity re- 
mained constant after this treatment. The inhibi- 
tion of control and NEM-treated Fl,(iP~ases by 
Fl,6P2 and F2,6P2 was then examined. Fig.2 
shows Dixon plots for the inhibition by high levels 
of F1,6P2. The values of Ki for F1,6P2 were 
150pM and 850 FM for the control and NEM- 
treated samples, respectively. This shows that the 
reaction of F1,6Pzase with NEM caused a very 
considerable reduction in the affinity of the en- 
zyme for F1,6P2 as an inhibitor. 
The inhibition by F2,6P2 is expressed in fig.3 as 
double reciprocal plots of velocity against F1,6P2 
concentration at different levels of F2,6P2. For the 
control F1,6Pzase F2,6P2 clearly induces co- 
operativity in the response to Fl,6P2 (fig.3a); the 
response to F2,6P2 is itself co-operative [141. These 
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results agree with those in [5]. For the NEM- 
treated enzyme F2,6Pz is a linear competitive in- 
hibitor with respect to Fl,6P2 and the enzyme 
responds hyperbolically to F1,6P2 (fig.3b). Slope 
replots of the data in fig.3b are linear (not shown), 
indicating that the NEM-treated enzyme does not 
respond co-operatively to F2,6P2. The Km of the 
NEM-treated enzyme for Fi,6P2 is 1.4 pM at 
2.0 mM free Mg’” ions (fig.3b); this is similar to 
the value for the control enzyme [14]. 
The simplest interpretation of these data in- 
volves the assumptions that FZ,6P2 can interact at 
two sites on Fl,GPzase, the catalytic site and an 
allosteric site, and that high substrate inhibition is 
caused by low affinity binding of F1,6Pz to the 
allosteric site. We assume that NEM reacts 
preferenti~ly with the one particularly reactive 
thiol group per subunit; the protection data sug- 
gest that this group is adjacent to or part of the 
allosteric site. The reaction of this thiol group with 
NEM seems to prevent binding of F2,6P2 to the 
allosteric site completely and to reduce the affinity 
of this site for F1,6Pz considerably. 
These ideas are compatible with much previous 
work on F1,6Pzases and go some way towards 
resolving the controversy concerning the 
mechanism of action of F2,6Pz.,The interaction of 
F2,6Pz with an allosteric site is supported by a 
number of observations. The effects of F2,6P2 and 
AMP are synergistic [2-6,141, F2,6Pz induces co- 
operativity in the response to Fl,6P2 [5,6,14] and 
F2,6P2 gives sigmoid inhibition of F1,6P2ase 
[5,14]. None of these effects would be expected of 
a simple competitive inhibitor. Moreover, F2,6Pz 
can protect the AMP site of rat liver Fl,CiPzase 
against modification by acetylimidazole 161 and 
can protect the rabbit liver enzyme against pro- 
teolysis [3] whereas levels of F1,6Pz sufficient to 
saturate the catalytic site but not to cause high 
substrate inhibition do not have these effects. Our 
observation that NEM both reduces the Ki for 
Fig.3. Inhibition of F1,6Pzase by F2,6P2. The 
fluorimetric assay was used and the free Mg2+ 
concentration was 2 mM. (a) Control F1,6Pzase. The 
F2,6P2 concentrations were 0 (o), 1.5 ,uM (A), 2.9 pM 
(A), 5.9,~M (0) and 11.8pM (m); (b) Fi,dPzase 
modified with NEM as described in the text. The F2,6P2 
concentrations were 0 (0), 1.2 pM (01, 2.4pM (A) and 
3.5 pM (A). 
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F1,6P2 as an inhibitor and eliminates the sigmoid 
component of the inhibition by F2,6Pz strongly 
suggests that the allosteric site for F2,6Pz can also 
bind F1,6Pz with low affinity and that this is 
responsible for the high substrate inhibition of the 
enzyme. In agreement with this, high levels of 
F1,6Pz cause little or no additional inhibition if 
F2,6P2 is present [5,14]. The fact that F2,6Pz is a 
simple linear competitive inhibitor of NEM-treated 
F1,6Pzase with respect to Fl,6P2 indicates that 
F2,6P2 can also bind to the catalytic site of the en- 
zyme. This is supported by the observations that 
F2,6Pz can protect the enzyme against inactivation 
by acetylimidazole [4,6] and pyridoxal phosphate 
131. 
Our suggestion that F2,6Pz can interact with 
F1,6Pzase at two distinct sites could be tested 
directly by binding studies. However, our model 
for the allosteric properties of rat liver Fl,6Pzase 
[14] indicates that binding of more than one 
molecule of F2,6P2 per subunit might be detectable 
only at high concentrations of F2,6Pz. Ultimately, 
crystallographic studies may be required to resolve 
this problem. 
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